$-0.37 EPS Expected for Chimerix (CMRX); 2 Analysts Are Bullish Endeavour Silver (TSE:EDR) Last Week

April 21, 2017 - By sdlfksdklf klsdf

Among 5 analysts covering Endeavour Silver Corp. (TSE:EDR), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Endeavour Silver Corp. had 23 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Sector Underperformer” rating on Tuesday, February 23 by IBC. BMO Capital Markets maintained Endeavour Silver Corp (TSE:EDR) rating on Wednesday, April 12. BMO Capital Markets has “Market Perform” rating and $5 target. Raymond James maintained the stock with “Market Perform” rating in Thursday, March 2 report. TD Securities maintained Endeavour Silver Corp (TSE:EDR) on Friday, November 4 with “Hold” rating. TD Securities downgraded the stock to “Reduce” rating in Tuesday, July 21 report. Canaccord Genuity maintained Endeavour Silver Corp (TSE:EDR) on Tuesday, October 25 with “Hold” rating. The firm has “Outperform” rating given on Tuesday, April 11 by Raymond James. Raymond James maintained Endeavour Silver Corp (TSE:EDR) on Thursday, January 26 with “Market Perform” rating. The rating was maintained by Raymond James with “” on Monday, April 3. The rating was initiated by Ringler Research with “Outperform” on Thursday, October 29. See Endeavour Silver Corp (TSE:EDR) latest ratings:

12/04/2017 Broker: BMO Capital Markets Rating: Market Perform New Target: $5.00 Maintain
11/04/2017 Broker: Raymond James Rating: Outperform New Target: $6.00 Maintain
03/04/2017 Broker: Raymond James Rating: New Target: $5.50 Maintain
03/03/2017 Broker: TD Securities Rating: Hold Old Target: $6.00 New Target: $5.00 Target Down
02/03/2017 Broker: Raymond James Rating: Market Perform New Target: $5.50 Maintain
26/01/2017 Broker: Raymond James Rating: Market Perform New Target: $4.75 Maintain
26/01/2017 Broker: National Bank Canada Rating: Old Target: $6.75 New Target: $6.50 Target Down
11/01/2017 Broker: IBC Rating: Old Target: $5.50 New Target: $5.00 Target Down
22/12/2016 Broker: Raymond James Rating: Old Target: $6.75 New Target: $4.75 Target Down
04/11/2016 Broker: IBC Rating: Old Target: $5.00 New Target: $5.50 Target Up

Analysts expect Chimerix Inc (NASDAQ:CMRX) to report $-0.37 EPS on May, 8.They anticipate $0.20 EPS change or 35.09% from last quarter’s $-0.57 EPS. After having $-0.32 EPS previously, Chimerix Inc’s analysts see 15.63% EPS growth. About 87,118 shares traded. Chimerix Inc (NASDAQ:CMRX) has risen 20.65% since September 14, 2016 and is uptrending. It has outperformed by 9.83% the S&P500.

About 181,803 shares traded. Endeavour Silver Corp (TSE:EDR) has declined 37.46% since September 14, 2016 and is downtrending. It has underperformed by 48.29% the S&P500.

Investors sentiment decreased to 1.47 in Q4 2016. Its down 0.19, from 1.66 in 2016Q3. It dropped, as 21 investors sold Endeavour Silver Corp shares while 60 reduced holdings. 31 funds opened positions while 88 raised stakes. 79.90 million shares or 1.04% more from 79.08 million shares in 2016Q3 were reported. Kanaly Tru reported 0% of its portfolio in Endeavour Silver Corp (TSE:EDR). Voya Investment Mgmt Limited Liability Com holds 0% or 30,832 shares in its portfolio. Da Davidson has 0.01% invested in Endeavour Silver Corp (TSE:EDR). Phocas Fincl Corporation accumulated 0.6% or 216,642 shares. Texas Permanent School Fund holds 0.03% or 53,277 shares. Farmers Merchants Invests Inc accumulated 109 shares. Guggenheim Limited Liability Company accumulated 190,456 shares. Old Natl Commercial Bank In holds 0.02% or 10,166 shares in its portfolio. Northern, Illinois-based fund reported 1.98M shares. Moreover, Kcg Holdings has 0.02% invested in Endeavour Silver Corp (TSE:EDR). Telemus Capital Limited Liability Company accumulated 5,000 shares. Teachers Ins Annuity Association Of America stated it has 76,609 shares or 0.11% of all its holdings. Spirit Of America Management New York invested in 55,275 shares or 0.27% of the stock. Invesco holds 0% or 345,806 shares. Quantbot Lp has invested 0.02% in Endeavour Silver Corp (TSE:EDR).

Endeavour Silver Corp. is engaged in silver mining in Mexico, and related activities, including property acquisition, exploration, development, mineral extraction, processing, refining and reclamation. The company has market cap of $542.03 million. The Firm is engaged in exploration activities in Chile. It has a 90.56 P/E ratio. The Company’s operating mining divisions include Guanacevi, Bolanitos and El Cubo, which are located in Mexico, as well as Exploration and Corporate divisions.

Since November 28, 2016, it had 2 insider buys, and 2 selling transactions for $1.21 million activity. 180 shares were bought by Thomas John T, worth $7,285 on Monday, November 28. The insider Cahill William J sold $406,200. $10,717 worth of Endeavour Silver Corp (TSE:EDR) was bought by Mackie Lindsey. Shares for $825,800 were sold by CHURCHEY RANDY L on Thursday, February 23.

Chimerix, Inc. is a biotechnology company. The company has market cap of $266.76 million. The Firm is focused on discovering, developing and commercializing medicines that address unmet medical needs. It currently has negative earnings. The Company’s lead compound, brincidofovir, is in development as an oral and intravenous formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses, including smallpox, adenoviruses (AdV), and the human herpesviruses.

Among 7 analysts covering Chimerix Inc (NASDAQ:CMRX), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Chimerix Inc had 16 analyst reports since August 5, 2015 according to SRatingsIntel. On Tuesday, February 23 the stock rating was downgraded by Morgan Stanley to “Underweight”. FBR Capital downgraded it to “Mkt Perform” rating and $14.0 target in Monday, December 28 report. FBR Capital maintained Chimerix Inc (NASDAQ:CMRX) on Tuesday, February 23 with “Mkt Perform” rating. On Thursday, December 17 the stock rating was initiated by UBS with “Buy”. On Tuesday, December 29 the stock rating was downgraded by JP Morgan to “Neutral”. As per Tuesday, December 29, the company rating was maintained by Barclays Capital. On Thursday, September 3 the stock rating was initiated by Citigroup with “Buy”. The stock has “Overweight” rating by Piper Jaffray on Monday, December 28. Brean Capital maintained Chimerix Inc (NASDAQ:CMRX) rating on Thursday, August 6. Brean Capital has “Buy” rating and $57 target. Barclays Capital downgraded the shares of CMRX in report on Tuesday, February 23 to “Equal-Weight” rating.

Investors sentiment decreased to 0.94 in Q4 2016. Its down 0.11, from 1.05 in 2016Q3. It worsened, as 16 investors sold Chimerix Inc shares while 31 reduced holdings. 12 funds opened positions while 32 raised stakes. 30.20 million shares or 8.41% less from 32.97 million shares in 2016Q3 were reported. Numeric Invsts Limited has 1.73M shares for 0.08% of their portfolio. State Common Retirement Fund has 36,400 shares. Moreover, Kcg has 0.01% invested in Chimerix Inc (NASDAQ:CMRX). Alps Advsrs has 0% invested in Chimerix Inc (NASDAQ:CMRX) for 44,508 shares. Panagora Asset Mngmt has 286,590 shares. Geode Capital Management Ltd Co owns 0% invested in Chimerix Inc (NASDAQ:CMRX) for 305,486 shares. Millennium Mngmt Limited Liability has 0.01% invested in Chimerix Inc (NASDAQ:CMRX) for 620,414 shares. Goldman Sachs Grp Inc invested in 33,061 shares or 0% of the stock. Northern Tru reported 595,668 shares. Blackrock Inv Ltd Llc holds 184,679 shares or 0% of its portfolio. Prudential has 0% invested in Chimerix Inc (NASDAQ:CMRX). Credit Suisse Ag accumulated 0% or 37,882 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 896 shares. Fmr Lc holds 0% or 6.94M shares in its portfolio. 1.42 million are owned by Ecor1 Capital Ltd Company.

Since December 27, 2016, it had 0 insider buys, and 1 sale for $464,367 activity. 100,000 shares were sold by MARIO ERNEST, worth $464,367.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Top News

No posts yet.
>